Investments abroad · VC firm · United Kingdom
Abingworth's investments in the United States
Abingworth, based in the United Kingdom, has backed 17 startups in the United States in rounds we track, $2.5B between them, grouped by their main sector.
Biotech
13
Funding by segment
- Biotech$1.8B13
- Pharma$615M2
- Healthtech$80M2
Where they are based
- United States17$2.5B
United StatesFounded
1 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M1
- $10M to $50M2
- $50M to $250M12
- $250M to $1B2
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
16 of 17 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States17
Startups by country, 1 country in all.
Segment by segment
Biotech
13 startups · $1.8B raised
Phathom PharmaceuticalsPhathom Pharmaceuticals is a biopharmaceutical company.United States$530M
GynesonicsGynesonics develops transcervical, uterus-preserving, incision-less technologies for diagnostic and therapeutic applications.United States$214M
Jasper TherapeuticsJasper Therapeutics is a biotechnology company that develops novel antibody therapies for stem cell transplants.United States$167M- SSutroVaxUnited States$167M
Atsena TherapeuticsAtsena Therapeutics is a clinical-stage gene therapy company based in Durham, North Carolina, focused on developing treatments forUnited States$150M
PersonalisPersonalis is a contract research organization and genome-scale diagnostics services company specializing in genome guided medicine.United States$125M
Effector TherapeuticsEffector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.United States$99M
Hydra BiosciencesHydra Biosciences is a biopharmaceutical company based in Cambridge, Massachusetts, founded in 2001.United States$95M
Pharma
2 startups · $615M raised
CRISPR THERAPEUTICSCRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.United States$550M
Thesan PharmaceuticalsThesan Pharmaceuticals is a preclinical biopharmaceutical company developing novel therapeutics for skin disorders.United States$65M
Healthtech
2 startups · $80M raised
Sonitus MedicalSonitus Medical provides clinically effective non-invasive and removable hearing solutions based on the bone conduction method.United States$68M
MD On-LineMDOL provides healthcare information solutions such as healthcare transaction EDI, practice management, EMR, and data analytics.United States$12M
How this map is made. Every startup here has raised money in a round we track that names Abingworth as an investor and is based in United States. Each sits under its main sector, read from its rounds, and each shows its best-funded first. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Abingworth?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.